The Importance of The EFHD2 Complex in Neural Development and Maintenance

Target Name: EFHD2

NCBI ID: G79180

EFHD2

The Importance of The EFHD2 Complex in Neural Development and Maintenance

Exploring the Potential Drug Targets and Biomarkers of EFHD2: Unraveling the Importance of theEFHD2 Complex in Neural Development and Maintenance

Introduction

Embryonic development and neural tube formation are critical processes in the development of higher organisms, and the defects in these processes can lead to various neurological and developmental disorders. One of the key factors influencing these processes is the expression of genes, particularly those involved in the development and maintenance of the nervous system. The EFHD2 gene, encoding a protein called EFHD2 (Embryonic Fetal Hedgehog-Domain Containing 2), has garnered significant interest in recent years due to its involvement in neural development and maintenance. In this article, we will explore the potential drug targets and biomarkers of EFHD2 and highlight its significance in the understanding of neurodevelopmental disorders.

The EFHD2 gene and its function

The EFHD2 gene was first identified in the mouse genome using transcriptomic and genomic approaches. The gene is located on chromosome 16 and encodes a protein with a unique structure that includes a N-terminal domain, a central domain, and a C-terminal domain. The N-terminal domain contains a critical region that includes a putative conserved domain-selective interaction (DDI) domain, which is known to play a crucial role in protein-protein interactions. The central domain contains several putative transmembrane domains, including a GFP- like domain, a T-score domain, and a N-terminal-like domain. The C-terminal domain includes a unique structural feature called a conserved helix-loop-helix (CCLH) domain, which is known to be involved in protein stability and localization.

EFHD2 functions as a negative regulator of the Wnt signaling pathway

The Wnt signaling pathway is a critical regulator of neural development and growth, and its abnormalities can lead to various neurodevelopmental disorders, including those affecting the brain. The EFHD2 gene has been shown to play a crucial role in regulating the Wnt signaling pathway. Specifically, studies have shown that EFHD2 can inhibit the activity of the Wnt receptor, which is a critical component of the Wnt signaling pathway. This inhibition leads to the inhibition of the Wnt signaling pathway, thereby contributing to the regulation of neural development and maintenance.

The role of EFHD2 in neural development and maintenance

EFHD2 has been shown to play a crucial role in the regulation of neural development and maintenance. Studies have shown that EFHD2 can negatively regulate the activity of the Wnt receptor, which is a critical component of the Wnt signaling pathway. This inhibition leads to the inhibition of the Wnt signaling pathway, thereby contributing to the regulation of neural development and maintenance.

In addition to its role in regulating the Wnt signaling pathway, EFHD2 has also been shown to play a crucial role in the regulation of cell adhesion and migration. Specifically, studies have shown that EFHD2 can interact with the cadhertide protein, which is involved in cell -cell adhesion. This interaction between EFHD2 and cadhertide protein highlights the role of EFHD2 in the regulation of cell-cell adhesion and migration, which is critical for the development and maintenance of neural tissues.

The potential drug targets and biomarkers of EFHD2

The potential drug targets and biomarkers of EFHD2 have implications for the understanding and treatment of various neurological and developmental disorders. Given its role in the regulation of neural development and maintenance, EFHD2 has potential as a drug target for treating disorders affecting the nervous system, such as cancer, neurodegenerative diseases, and developmental disorders.

One potential drug target for EFHD2 is the inhibition of its activity

Protein Name: EF-hand Domain Family Member D2

Functions: May regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. Plays a role as negative regulator of the canonical NF-kappa-B-activating branch. Controls spontaneous apoptosis through the regulation of BCL2L1 abundance

The "EFHD2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFHD2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets